Tradestie Institutional Equity Comparison Engine

LABU vs LABD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LABU Overall Edge

LABU Captures Institutional Edge (2โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Direxion Daily S&P Biotech Bull 3X Shares (LABU) driven by superior Momentum & Technical, Options & Structure. Fundamentally, LABU trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus LABD at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, LABU sits in UNCLASSIFIED (12th %ile IV; Dealer Gamma Walls on Pro) against LABD sits in UNCLASSIFIED (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
LABU N/M vs LABD N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner LABU
1Y +54.0% vs -71.3% ยท 52W Pos 33% vs 10%
Options & Structure Winner LABU
UNCLASSIFIED (12th %ile IV) vs UNCLASSIFIED (18th %ile IV)
LABU NYSE Arca
Direxion Daily S&P Biotech Bull 3X Shares
Institutional Equity
$195.22
-9.13% 1D
Market Cap N/A
1M Return -1.83%
1Y Return +53.97%
Forward P/E N/M
Unified AI Score
49.4 / 100 HOLD
Tech 25.0 Fund 39.0 Flow 50.0 Mom 40.0
LABD NYSE Arca
Direxion Daily S&P Biotech Bear 3X Shares
Institutional Equity
$8.09
+9.03% 1D
Market Cap N/A
1M Return -9.71%
1Y Return -71.33%
Forward P/E N/M
Unified AI Score
51.2 / 100 HOLD
Tech 65.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LABU +53.97% LABD -71.33% Spread: +125.3 pp (LABU Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LABU TTM Op. Margin: N/A LABD TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LABU vs LABD. Trailing 12-month operating profitability (LABU N/A vs LABD N/A) and valuation multiples (LABU N/M vs LABD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LABU (2) vs LABD (1)
Institutional Metric LABU LABD Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 33% ($124โ€“$342) 10% ($6โ€“$29) Stronger Trend LABU
Beta / 30D Volatility Risk Regime 3.71ฮฒ ยท 119% Vol -3.71ฮฒ ยท 120% Vol Lower Realized Risk LABU
Unified Institutional Score Composite Signal 49.4 / 100 (HOLD) 51.2 / 100 (HOLD) Higher Composite LABD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LABU vs LABD Buy Guide
LABU UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live LABU Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LABD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live LABD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LABU nor LABD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.